MLTX vs STX · $1.41B cap vs P/E 101, rev $12.20B
MoonLake Immunotherapeutics (MLTX) versus Seagate Technology PLC (STX) — a side-by-side from cached financials, not a winner call.
MoonLake Immunotherapeutics (MLTX) is a biotechnology company listed on US.
Seagate Technology PLC (STX) is a computer hardware company listed on NASDAQ.
MLTX does not have a complete income-statement cache yet.
Latest reported STX revenue for 2026-07-03 was $12.20B. Net income was $3.18B. Revenue was up 34.1% from 2025-06-27 to 2026-07-03. STX currently screens at market cap $241.20B and trailing P/E 101.3.
MLTX currently screens at market cap $1.41B. STX currently screens at market cap $241.20B and trailing P/E 101.3.
Not investment advice. Open the MLTX and STX stock pages for the full models.
Not investment advice.